Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Consumer Mobile Health Apps: Current State, Barriers, and Future Directions.
Chemistry and biology of reactive oxygen species in signaling or stress responses.
Epidemiology of gastrointestinal bleeding in adult patients on extracorporeal life support.
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine.
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut. 2007 Sep; 56(9):1232-9.
View in:
PubMed
subject areas
Adalimumab
Adult
Antibodies
Antibodies, Antinuclear
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents
Crohn Disease
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents
Injections, Subcutaneous
Long-Term Care
Male
Treatment Outcome
authors with profiles
Stephen B. Hanauer